ChinaBiz Briefing | CATL’s Fusion Bet, Data Glut, AI Pharma Race, and NIO Refreshed L60

ChinaBiz Briefing | CATL’s Fusion Bet, Data Glut, AI Pharma Race, and NIO Refreshed L60

Today’s developments highlight a structural pivot in Chinese tech and capital. While legacy internet giants and battery leaders aggressively diversify into frontier sectors like AI drug discovery and nuclear fusion, hardware markets—from EV price wars to a looming AI infrastructure build-out—are flashing oversupply warnings. These moves underscore a market bifurcating between high-risk, long-term innovation and cutthroat near-term consolidation.

CATL Pivots to Nuclear Fusion with Beta Fusion Investment 

Contemporary Amperex Technology (CATL), the world's top EV battery maker, led a multi-hundred-million-yuan seed round in Beijing-based Beta Fusion. The startup focuses on the high-risk, fast-iteration Field-Reversed Configuration (FRC) fusion pathway, targeting a grid-connected demonstration plant within 6–8 years. 

Why it matters: This marks CATL's first strategic leap beyond batteries toward becoming a vertically integrated clean energy supplier, aligning with its ambition to build a zero-carbon grid business ten times larger than its EV segment. As AI data centers drive surging baseload power demand, the deal mirrors U.S. hyperscaler bets (like Microsoft and Helion) and highlights the accelerating momentum of China's private fusion sector.

Tech Giants Restructure Around $556B AI Pharma Market 

A flurry of moves this week saw China's biggest internet platforms dive into AI drug discovery and cell therapy. ByteDance spun out its AI pharma unit to build a full-stack pipeline, Baidu-backed BioMap filed for a Hong Kong IPO, Tencent patented an AI-designed GLP-1 drug, while Alibaba and JD Health leveraged their supply chains to enter cell therapy. 

Why it matters: Triggered by a new May 2026 state regulation clarifying the commercial pathway for biomedical tech, this synchronized pivot shows platforms moving from passive investors to active drug originators and infrastructure providers. The ultimate battleground is no longer just algorithmic performance, but the accumulation of proprietary life-sciences data to build durable, compounding moats.

Deutsche Bank Warns of US$278B AI Data Center Oversupply

Deutsche Bank cautioned that Beijing's state-directed US$278 billion AI data center build-out could double China's computing capacity to 76GW by 2031. The report triggered an 8.5% drop in Alibaba shares amid fears that state-owned telecom operators, armed with open-source models like DeepSeek, could ignite a cloud price war.

Why it matters: While the massive infrastructure push provides near-term tailwinds for data center builders, it risks engineering a structural oversupply that could crush margins by the late 2020s. For private cloud providers like Alibaba, defending enterprise market share against subsidized state telcos will be critical to long-term profitability.

Morgan Stanley Backs NIO Following Disruptive L60 Relaunch 

NIO launched a refreshed Onvo L60 priced 7–13% lower than its predecessor (starting at ~$26,800), despite upgrading to its in-house 5nm Shenji chip and standardizing its autonomous driving architecture. Morgan Stanley reaffirmed its Overweight rating, projecting the aggressive pricing could push NIO’s Q2 deliveries toward the upper end of its 115,000-unit target. 

Why it matters: The refresh completes NIO’s platform unification strategy, which significantly lowers per-unit software development costs. By undercutting rivals like the Tesla Model Y while offering advanced LiDAR options, NIO is betting that an aggressive entry price will drive a high-margin mix-shift, accelerating its timeline to projected profitability by 2028.

Huawei Retains Global Smartwatch Crown as Market Bifurcates 

Huawei held its position as the top global smartwatch vendor in Q1 2026 with a 20.2% market share (9.5 million shipments), despite a 4.6% year-over-year decline. Apple followed with 17%, while Samsung suffered a sharp 20.7% drop to fourth place, according to IDC data. 

Why it matters: The data reveals a bifurcating global wearables market where budget devices and premium tech thrive, while mid-tier players like Samsung face severe headwinds. Crucially, China's domestic demand remains the primary engine of global smartwatch growth, insulating domestic champions like Huawei even as their international expansion plateaus.


What to Watch Next: Keep an eye on Q2 delivery figures from Chinese EV makers in early July to see if NIO’s aggressive pricing strategy pays off in volume. Additionally, as state-funded AI infrastructure scales, monitor upcoming cloud pricing adjustments from Alibaba and Tencent to gauge the severity of the telco-driven price war.

Related Coverage:

CATL Makes First Nuclear Fusion Bet, Leading Seed Round in Beijing-Based Beta FusionMorgan Stanley Sees NIO’s Refreshed L60 as “Positive Surprise,” Reaffirms OverweightDeutsche Bank: China’s RMB 2 Trillion AI Data Center Gamble Faces Oversupply CliffChina’s Tech Giants Race Into AI Pharma With Five Distinct Playbooks
Huawei Holds Global Smartwatch Crown in Q1 2026 as Samsung Slips to Fourth

Subscribe to ChinaBiz Insider

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
[email protected]
Subscribe